TITLE

Strong Protective Effect of DR3 Against Ulcerative Colitis in the Spanish Population

AUTHOR(S)
Gómez-García, María; Oliver, Javier; Márquez, Ana; Mendoza, Juan L.; López-Nevot, Miguel Ángel; Fernández-Arquero, Miguel; González-Escribano, María F.; Díaz-Rubio, Manuel; Concha, Emilio G. de la; Urcelay, Elena; Martín, Javier; Martínez, Alfonso
PUB. DATE
December 2007
SOURCE
American Journal of Gastroenterology;Dec2007, Vol. 102 Issue 12, p2762
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVES: Ulcerative colitis (UC) is a chronic inflammatory disease affecting the colon. Major histocompatibility complex (MHC) on the short arm of human chromosome 6 has been thoroughly studied as a susceptibility locus. However, one of the strongest MHC associations found, that of HLA-DR3 with UC protection, has not been observed in all populations. Our aim in the present study was to evaluate this negative association in a large cohort of Spanish UC patients and controls, and to try to elucidate which, if any, of the diverse DR3 haplotypes (identified by TNFa and b microsatellites, located in the MHC class III region) is most tightly associated (negatively) with the disease. METHODS: A total of 537 UC patients and 748 healthy controls from Spain were included in the present study. Low-resolution DR genotyping was performed by PCR and hybridization with allele-specific oligonucleotide probes. TNFa and b microsatellites were studied in a subset of samples (279 UC patients and 503 healthy controls) by PCR followed by capillary electrophoresis. DR-TNFa-TNFb haplotypes were estimated by the expectation-maximization algorithm and comparisons were performed by a χ2 test. RESULTS: After a stepwise procedure, the only DR alleles significantly associated with the disease were DR3 (very strongly, protection) and DR4 (weakly, protection). The strong protective effect of DR3 was evenly distributed among the haplotypes DR3-TNFa1b5, DR3-TNFa2b3, and DR3-TNFother. CONCLUSIONS: Our results confirm the strong protective effect of DR3 in our population, and suggest that the relevant protective gene is located centromeric to TNFa and TNFb markers in the MHC region.
ACCESSION #
27609314

 

Related Articles

  • Assessment of heterogeneity between European Populations: a Baltic and Danish replication case-control study of SNPs from a recent European ulcerative colitis genome wide association study.  // BMC Medical Genetics;2011, Vol. 12 Issue 1, p139 

    The article discusses a study which assessed the role of 11 newly identified ulcerative colitis (UC) risk variants, derived from a recent European UC genome wide association study (GWAS). As part of the study, eleven SNPs were replicated in a Danish sample consisting of 560 UC patients and 796...

  • A Search for the Optimal Duration of Treatment with 6-Mercaptopurine for Ulcerative Colitis. Lobel, Efrat Z.; Korelitz, Burton I.; Xuereb, Mark A.; Panagopoulos, Georgia // American Journal of Gastroenterology;Mar2004, Vol. 99 Issue 3, p462 

    BACKGROUND AND AIMS: 6-mercaptopurine has proven to be effective in the treatment and maintenance of remission of ulcerative colitis (UC). The optimal duration of treatment with 6-MP is unknown. The intention of this study was to determine the best duration of treatment with 6-MP in terms of...

  • Functional correlates of the interleukin-1 receptor antagonist gene polymorphism in the colonic mucosa in ulcerative colitis. Carter, M.J.; Jones, S.; Camp, N.J.; Cox, A.; Mee, J.; Warren, B.; Duff, G.W.; Lobo, A.J.; di Giovine, F.S. // Genes & Immunity;Jan2004, Vol. 5 Issue 1, p8 

    Association studies have identified the interleukin-1 receptor antagonist gene allele 2(IL-1RN*2) as a marker of susceptibility in ulcerative colitis (UC). This study investigated the significance of the IL-1RN genotype with respect to protein and mRNA expression in the colonic mucosa....

  • In Brief.  // Nature Reviews Immunology;Jun2008, Vol. 8 Issue 6, p401 

    The article presents short summaries of various research related to immunology in the U.S. One research shows that gut cryptopatches could be a potential source of local intraepithelial lymphocytes (IELs) precursors. Another research identifies several new genetic risk variants linked with the...

  • Immune Abnormalities and Endotoxemia in Patients with Ulcerative Colitis and in Their First Degree Relatives: Attempts at Neutralizing Endotoxin- Mediated Effects. Amati, L.; Caradonna, L.; Leandro, G.; Magrone, T.; Minenna, M.; Faleo, G.; Pellegrino, N.M.; Jirillo, E.; Caccavo, D. // Current Pharmaceutical Design;Sep2003, Vol. 9 Issue 24, p1937 

    Proinflammatory cytokines released from monocytes / macrophages, in particular tumor necrosis factor (TNF)-α, interleukin (IL)-1, IL-6, and IL-8 seem to play an important role in Inflammatory Bowel Disease (ulcerative colitis and Crohn's disease). Endotoxins or lipopolysaccharides, derived...

  • Sensorineural hearing loss and status epilepticus associated with ulcerative colitis: Is there enough evidence to support immune-related mechanisms? Yazici, Sinem; Benbir, Gulcin; Ince, Birsen // Journal of Neurosciences in Rural Practice;Jan-Mar2015, Vol. 6 Issue 1, p77 

    Ulcerative colitis (UC) is characterized by an inflammatory disorder of the gastrointestinal tract. Immune-mediated extraintestinal manifestations of UC have increasingly attracted attention in the literature recently, for which UC is now considered as a systemic disease. Neurologic involvement...

  • Recent Indications and Methods of Surgery for Inflammatory Bowel Disease. S. Ohki; S. Terashima; K. Sekikawa; S. Takenoshita; M. Gotoh // Current Drug Targets - Inflammation & Allergy;Jun2003, Vol. 2 Issue 2, p113 

    Inflammatory bowel disease, notably ulcerative colitis (UC) or Crohn disease (CD), is basically benign, but sometimes develops into serious or fatal cancer. While the primary therapies are medical, such as pharmacotherapy and dietetic modification, intractable, serious, and cancerous cases can...

  • Ulcerative colitis. Ghosh, Subrata // BMJ: British Medical Journal (International Edition);04/22/2000, Vol. 320 Issue 7242, p1119 

    Provides information on ulcerative colitis. Clinical features and diagnosis; Etiology; Clinical management; Failure of medical management and its indications for surgery.

  • What's new in inflammatory bowel disease in 2008? Baumgart, Daniel C. // World Journal of Gastroenterology;1/21/2008, Vol. 14 Issue 3, p329 

    Ulcerative colitis and Crohn's disease represent the two major forms of inflammatory bowel disease. In this highlight topic series of articles we cover the latest developments in genetics and epidemiology, intestinal physiology, mucosal immunology, mechanisms of epithelial cell injury and...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics